Literature DB >> 22193515

Rapid and direct detection of Invivo kinetics of pathogenic bacterial infection from mouse blood and urine.

Judy Gopal1, Chia-Hsun Lee, Hui-Fen Wu.   

Abstract

This study demonstrates the first use of matrix assisted laser desorption/ionization mass spectrometry (MALDI-MS) to trace the Invivo infection kinetics of the well known deadly pathogen Staphylococcus aureus in Swiss albino mice. The growth curve of the bacteria from the point of injection (200μL of bacterial suspension (10(8)cfu/mL)) into the mouse blood till mortality (death) was periodically analyzed using the plate counting method and MALDI-MS. Bacterial counts of 10(3)cfu/mL were observed in the log phase of the growth curve in the blood and 10(2)cfu/mL were observed in the urine samples. Death occurred in the log phase of the growth curve, where the bacterial counts showed steady increase. In other cases, the bacteria counts started decreasing after 48h and by 96h the bacteria got totally eliminated from the mouse and these mice survived. Direct MALDI-MS was not feasible for tracking the bacteria in the infected blood. However, ionic liquid 1-Butyl-3-methylimidazolium tetrafluoroborate was successful in enabling bacterial detection amidst the strong blood peaks. But, in the case of the urine analysis, it was observed that direct MALDI-MS was adequate to enable detection. The results obtained prove the efficacy of MALDI-MS for analyzing pathogenic bacteria in clinical samples. This article is part of a Special Issue entitled: Proteomics: The clinical link.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22193515     DOI: 10.1016/j.jprot.2011.12.004

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  1 in total

1.  Advanced mass spectrometry technologies for the study of microbial pathogenesis.

Authors:  Jessica L Moore; Richard M Caprioli; Eric P Skaar
Journal:  Curr Opin Microbiol       Date:  2014-07-03       Impact factor: 7.934

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.